Stock detail
Incyte (INCY) stock price, chart, and key data
View Incyte stock price, chart movement, and headline metrics on Woodstock's stock detail page.
Stock detail
Incyte
INCY · XNAS
+$2.16 (+2.27%) past month
$97.16
After hours $97.02 (-0.15%)
Key metrics
Close price
$97.16
Day range
$58.50 - $59.32
52-week range
$62.84 - $112.29
Market cap
$19.5B
About the company
Incyte Genomics Inc
Incyte focuses on the discovery and development of small-molecule drugs. The firm's leading drug, Jakafi, treats two types of rare blood cancer and graft versus host disease and is partnered with Novartis. Incyte's other marketed drugs include rheumatoid arthritis treatment Olumiant (licensed to Lilly), and oncology drugs Iclusig (chronic myeloid leukemia), Pemazyre (cholangiocarcinoma), Tabrecta (lung cancer), and Monjuvi (diffuse large B-cell lymphoma). The firm's first dermatology product, Opzelura, was approved in 2021 for atopic dermatitis and 2022 for vitiligo. Incyte's pipeline includes an array of oncology and dermatology programs.
24/5 Trading
Act on the stock when the timing works for you.
With Woodstock, you can move from chart review to order placement in one flow. Trade eligible US stocks 24/5, even outside regular market hours.
*24-hour trading is available except during system maintenance. Some stocks are not eligible for extended-hours trading.
Download the app